Comparison of four methods for detection of teicoplanin resistance in methicillin-resistant Staphylococcus aureus

The Journal of Antimicrobial Chemotherapy
R CharlesworthA P R Wilson

Abstract

To determine which method of determining the MIC of teicoplanin produces a result closely related to outcome in the critically ill patient. Four methods of teicoplanin susceptibility testing-disc diffusion, Etest, VITEK (Legacy and VITEK 2) and agar incorporation-were compared for 47 methicillin-resistant Staphylococcus aureus (MRSA) isolates from invasive intensive care unit (ICU) infections and 83 isolates from ICU patients colonized with the organism. Clinical outcome was recorded prospectively for all the patients. Another 13 reference laboratory strains of MRSA with reduced susceptibility to teicoplanin were tested. Both VITEK systems failed to demonstrate resistance in the three isolates identified as resistant by Etest or agar incorporation, and disc testing detected only one resistant isolate. A higher MIC, as found by Etest or agar incorporation, was associated with lower survival (n = 130, 95% CI -0.082 to -0.006, P = 0.023, Etest; n = 130, 95% CI -0.156 to -0.020, P = 0.011, agar). The findings for the 13 reference strains were similar, with a > or = 4-fold reduction in MIC between agar incorporation or Etest and VITEK2 for six isolates. Neither disc diffusion nor the VITEK systems are reliable for detection of teico...Continue Reading

Citations

Feb 4, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S J van HalD L Paterson
Oct 10, 2008·The Journal of Antimicrobial Chemotherapy·Russell HopeUNKNOWN BSAC Working Parties on Resistance Surveillance
Sep 25, 2012·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Ke-Yuan ChenMing-Hsun Lee
Jul 24, 2012·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Zulfiqar Ali Mirani, Nusrat Jamil
Dec 8, 2009·The Journal of Infection·Pak-Leung HoRichard Y Kao
May 18, 2007·International Journal of Antimicrobial Agents·I M Gould
Jul 6, 2006·The Journal of Hospital Infection·A P R WilsonG Bellingan
Jan 9, 2010·Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis·G Tuncer ErtemB Oral
Aug 10, 2012·Annals of Clinical Biochemistry·Francis H Y FungAndrew S Davison

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.